Who
J. Stanley Fredrick
Director
Company insider
Files Form 4 as: Director and 10% owner and Other, Mannatech.
In numbers
- Trades disclosed
- 46
- Buys
- 11
- Sells
- 0
- Bought
- $222K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 27 Dec 2006
- Last trade
- 2 Jan 2026
- Last filed
- 6 Jan 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Jan 2026filed 6 Jan 2026 | MTEX MannatechPharmaceuticals | SEC FORM 4 Code A | $40K4,790 at $8.35 | filing |
| 2 Jan 2026filed 6 Jan 2026 | MTEX MannatechPharmaceuticals | SEC FORM 4 Code A | $40K4,790 at $8.35 | filing |
| 4 Jun 2025filed 5 Jun 2025 | MTEX Mannatechoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —5,000 at $0.00 | filing |
| 2 Jan 2025filed 6 Jan 2025 | MTEX MannatechPharmaceuticals | SEC FORM 4 Code A | $40K2,686 at $14.89 | filing |
| 2 Jan 2024filed 4 Sep 2024 | MTEX MannatechPharmaceuticals | SEC FORM 4 Code A | $40K4,932 at $8.11 | filing |
| 2 Jan 2024filed 5 Jan 2024 | MTEX MannatechPharmaceuticals | SEC FORM 4 Code A | $40K4,932 at $8.11 | filing |
| 3 Jan 2023filed 5 Jan 2023 | MTEX MannatechPharmaceuticals | SEC FORM 4 Code A | $40K2,294 at $17.43 | filing |
| 15 Jun 2022filed 16 Jun 2022 | MTEX Mannatechoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —5,000 at $0.00 | filing |
| 3 Jan 2022filed 5 Jan 2022 | MTEX MannatechPharmaceuticals | SEC FORM 4 Code A | $40K1,012 at $39.49 | filing |
| 24 Aug 2021filed 25 Aug 2021 | MTEX Mannatechoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —5,000 at $0.00 | filing |
| 24 Aug 2021filed 25 Aug 2021 | MTEX MannatechPharmaceuticals | SEC FORM 4 Code M | $29K5,000 at $5.72 | filing |
| 4 Jan 2021filed 5 Jan 2021 | MTEX MannatechPharmaceuticals | SEC FORM 4 Code A | $35K1,873 at $18.68 | filing |
| 24 Sep 2020filed 30 Sep 2020 | MTEX MannatechPharmaceuticals | SEC FORM 4 Bought | $58K3,510 at $16.48 | filing |
| 2 Jan 2020filed 7 Jan 2020 | MTEX MannatechPharmaceuticals | SEC FORM 4 Code A | $35K2,229 at $15.70 | filing |
| 2 Jan 2020filed 6 Jan 2020 | MTEX MannatechPharmaceuticals | SEC FORM 4 Code A | $35K2,201 at $15.90 | filing |
| 26 Nov 2019filed 27 Nov 2019 | MTEX MannatechPharmaceuticals | SEC FORM 4 Bought | $25K1,500 at $16.47 | filing |
| 30 Sep 2019filed 2 Oct 2019 | MTEX MannatechPharmaceuticals | SEC FORM 4 Bought | $87751 at $17.20 | filing |
| 26 Sep 2019filed 2 Oct 2019 | MTEX MannatechPharmaceuticals | SEC FORM 4 Bought | $8,425500 at $16.85 | filing |
| 12 Jun 2019filed 14 Jun 2019 | MTEX Mannatechoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —5,000 at $0.00 | filing |
| 29 Mar 2019filed 2 Apr 2019 | MTEX MannatechPharmaceuticals | SEC FORM 4 Bought | $44K2,500 at $17.75 | filing |
News
Analyzing Edgewell Personal Care (NYSE:EPC) and Mannatech (NASDAQ:MTEX)MTEX · themarketsdaily.com · 17 Oct 2026
0 headlines in the last 90 days name J. Stanley Fredrick; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.